Skip to main navigation
Logo
  • Careers
  • Contact
  • Home
  • Company
    • Founder's Story
    • Senior Management
    • Board of Directors
  • Products
    • Overview
    • SUFENTANIL
    • DSUVIA
    • DZUVEO
    • Zalviso US
    • Zalviso EU
  • Partnering
  • Investors
    • Overview
    • News & Events
    • Stock Information
    • SEC Filings
    • Corporate Governance
    • Shareholder Services
  • Media
    • Overview
    • Press Releases
    • Publications
  • Military
  • Careers
  • Contact

Investors

Contents

SEC Filing Details

Document Details

Form
S-3/A
Filing Date
Apr 22, 2022
Document Date
Apr 22, 2022
Form Description
Pre-effective amendment to an S-3 filing
Filing Group
Registration Statements
Company
AcelRx Pharmaceuticals, Inc.
Issuer
ACELRX PHARMACEUTICALS INC

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS
  • Print Page
  • RSS Feeds
  • Overview
  • News & Events
  • Stock Information
  • SEC Filings
  • Corporate Governance
  • Shareholder Services
  

© 2022 AcelRx Pharmaceuticals, Inc. All Rights Reserved.

Privacy Policy | Terms of Use | CA state requirements
NP-US-NP-0002   05/21